Explore
Trendline
Goldman Sachs Identifies Dot-Com Era Market Concentration in S 500 Driven by Mega-Cap Tech
Goldman Sachs Identifies Dot-Com Era Market Concentration in S 500 Driven by Mega-Cap Tech
Read More
Trendline
David Rubenstein, Orioles Owner and Carlyle Group Co-founder, Cautions on AI Investment Boom
David Rubenstein, Orioles Owner and Carlyle Group Co-founder, Cautions on AI Investment Boom
Read More
TheStreet
Veteran Needham analyst sees 44% upside in tumbling health stock
Needham thinks the worst-case outcome for the MRI, CT, and ultrasound machine maker may already be fading.
Read More
TheStreet
Why Richard Ross is buying semiconductors after the AI pullback
The Evercore ISI technical analyst sees semiconductor and AI infrastructure stocks as buyable after their summer decline, but says a sustained rise in the 10-year Treasury yield above 5% would challenge his bullish case.
Read More
TheStreet
Bank of America drops bombshell verdict on Nike stock
The bank reset its price target on Nike.
Read More
Trendline
Goldman Sachs Warns of Tight Fuel Market Through 2027, Benefiting Refiners Like Marathon Petroleum
Goldman Sachs Warns of Tight Fuel Market Through 2027, Benefiting Refiners Like Marathon Petroleum
Read More
Trendline
Humana Stock Rises Following Barclays Upgrade to 'Overweight'
Humana Stock Rises Following Barclays Upgrade to 'Overweight'
Read More
Reuters
Global equity funds snap two-week outflow as AI optimism returns
Sept 25 (Reuters) - Global equity funds attracted the most inflows since early July in the week to September 25, snapping a two-week selling streak as enthusiasm around artificial intelligence and a pullback of oil prices outweighed a sharp rise in government bond yields.
Read More
TheStreet
Franklin Templeton CEO drops 7-word verdict for AI stock investors
Jenny Johnson's blunt assessment exposes what AI bulls still cannot prove.
Read More
Reuters
City Therapeutics files for US IPO as biotech listings surge
Sept 24 (Reuters) - City Therapeutics filed for a US initial public offering on Thursday, joining a rush of biotech firms lining up to tap the fall IPO window.
Read More
Trendline
ConocoPhillips Faces Investor Scrutiny Ahead of Earnings Report Amidst Low Forward P/E and Rising Estimates
ConocoPhillips Faces Investor Scrutiny Ahead of Earnings Report Amidst Low Forward P/E and Rising Estimates
Read More
TheStreet
Kevin Mahn: Market timing will cost you big
Mahn believes investors who wait for the “perfect dip” risk missing out on even bigger rebound days; he also recommends keeping cash on hand for opportunities that fit your goals.
Read More